NRC Health Stock: price and insider trades · United States

NRC Health is a listed company. Its insiders report their share dealings to SEC (Form 4). Between 18 October 2025 and 18 October 2026, 10 insiders published 11 filings.

Only purchases show up on the open market, 1 purchase in all worth €83k, filed by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 finance chief. One trade stands out by size: a purchase of €83k from Harrison Shane R, disclosed on 19 February 2026.

The latest purchase dates back some time: it was published 241 days ago, on 19 February 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4.

With 11 filings in twelve months, the company is quieter than the median of 22 filings across the 5,458 companies we follow on the same exchange. Over the whole record (from 2016), the tally stands at 3 purchases and 59 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 137.4 m USD and net income at 11.6 m USD; the dividend was 0.52 USD per share.

For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.